Technology announced that Nimbl, its next-generation pneumatic compression platform, is now commercially available ...
The results showed that BIS was more effective in identifying patients who would benefit from early compression therapy, leading to a lower progression rate to chronic lymphedema compared to TM[2].
On the heels of Nimbl’s launch for patients with upper extremity swelling, we are pleased to now expand access to the 16 million Americans with chronic swelling in the lower extremities,” said Sheri ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results